226 related articles for article (PubMed ID: 31979029)
1. The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto's Thyroiditis: An in Vitro Model of Thyroid Autoimmunity.
Ząbczyńska M; Polak K; Kozłowska K; Sokołowski G; Pocheć E
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31979029
[TBL] [Abstract][Full Text] [Related]
2. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
3. Altered N-glycan profile of IgG-depleted serum proteins in Hashimoto's thyroiditis.
Ząbczyńska M; Link-Lenczowski P; Novokmet M; Martin T; Turek-Jabrocka R; Trofimiuk-Müldner M; Pocheć E
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129464. PubMed ID: 31669586
[TBL] [Abstract][Full Text] [Related]
4. The expression and function of the neonatal Fc receptor in thyrocytes of Hashimoto's thyroiditis.
Zhao C; Gao Y; Zhao L; Li Y; Zhang Y; Wang S; Zhang H; Lu G; Guo X
Int Immunopharmacol; 2017 Mar; 44():53-60. PubMed ID: 28081504
[TBL] [Abstract][Full Text] [Related]
5. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
[TBL] [Abstract][Full Text] [Related]
6. Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients.
Yuan S; Li Q; Zhang Y; Huang C; Wu H; Li Y; Liu Y; Yu N; Zhang H; Lu G; Gao Y; Gao Y; Guo X
J Clin Endocrinol Metab; 2015 Feb; 100(2):717-24. PubMed ID: 25380293
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease.
Metcalfe RA; Oh YS; Stroud C; Arnold K; Weetman AP
Autoimmunity; 1997; 25(2):65-72. PubMed ID: 9189007
[TBL] [Abstract][Full Text] [Related]
8. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
[TBL] [Abstract][Full Text] [Related]
9. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.
Chiovato L; Bassi P; Santini F; Mammoli C; Lapi P; Carayon P; Pinchera A
J Clin Endocrinol Metab; 1993 Dec; 77(6):1700-5. PubMed ID: 7903315
[TBL] [Abstract][Full Text] [Related]
10. Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease.
Sack J; Baker JR; Weetman AP; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1986 May; 62(5):1059-64. PubMed ID: 3754262
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.
Bogner U; Schleusener H; Wall JR
J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225
[TBL] [Abstract][Full Text] [Related]
12. The role of
Trzos S; Link-Lenczowski P; Pocheć E
Front Immunol; 2023; 14():1188838. PubMed ID: 37575234
[TBL] [Abstract][Full Text] [Related]
13. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.
Xie LD; Gao Y; Li MR; Lu GZ; Guo XH
Clin Exp Immunol; 2008 Nov; 154(2):172-6. PubMed ID: 18778360
[TBL] [Abstract][Full Text] [Related]
14. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease.
Rebuffat SA; Nguyen B; Robert B; Castex F; Peraldi-Roux S
J Clin Endocrinol Metab; 2008 Mar; 93(3):929-34. PubMed ID: 18073303
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.
Ehlers M; Thiel A; Bernecker C; Porwol D; Papewalis C; Willenberg HS; Schinner S; Hautzel H; Scherbaum WA; Schott M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1347-54. PubMed ID: 22259066
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.
Rebuffat SA; Morin M; Nguyen B; Castex F; Robert B; Péraldi-Roux S
Br J Cancer; 2010 Mar; 102(5):852-61. PubMed ID: 20145622
[TBL] [Abstract][Full Text] [Related]
17. The pathogenic role of circulating Hashimoto's Thyroiditis-derived TPO-positive IgG on fetal loss in naïve mice.
Borodina E; Katz I; Antonelli A; Gzgzyan AM; Dzhemlikhanova LK; Ostrinski Y; Niauri D; Khizroeva J; Bitsadze V; Makatsariya A; Tincani A; Nalli C; Churilov LP; Shovman O; Halpert G; Blank M; Shoenfeld Y; Amital H
Am J Reprod Immunol; 2021 Jan; 85(1):e13331. PubMed ID: 32893404
[TBL] [Abstract][Full Text] [Related]
18. The expression of Fcγ receptors in Hashimoto's thyroiditis.
Liu Y; Liu M; Zhang Y; Qu C; Lu G; Huang Y; Zhang H; Yu N; Yuan S; Gao Y; Gao Y; Guo X
Cell Immunol; 2015 Mar; 294(1):33-8. PubMed ID: 25670392
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
20. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
